DrugPatentWatch Database Preview

Details for Patent: 7,470,720

Which drugs does patent 7,470,720 protect, and when does it expire?

Patent 7,470,720 protects HALAVEN and is included in one NDA.

This patent has thirty-eight patent family members in twenty-one countries.

Summary for Patent: 7,470,720

Title:	Methods and compositions for use in treating cancer
Abstract:	The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer.
Inventor(s):	Littlefield; Bruce A. (Andover, MA), Towle; Murray J. (Auburn, NH)
Assignee:	Eisai R&D Management Co., Ltd. (Tokyo, JP)
Application Number:	10/687,526
Patent Claim Types: see list of patent claims	Composition; Compound; Formulation;

Drugs Protected by US Patent 7,470,720

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Eisai Inc	HALAVEN	eribulin mesylate	SOLUTION;INTRAVENOUS	201532-001	Nov 15, 2010		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 7,470,720

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
6,469,182	Intermediates in the preparation of macrocyclic analogs	➤ Sign Up
6,653,341	Methods and compositions for use in treating cancer	➤ Sign Up
8,097,648	Methods and compositions for use in treating cancer	➤ Sign Up
6,214,865	Macrocyclic analogs and methods of their use and preparation	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Patents Family Members for US Patent 7,470,720

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2755266	➤ Sign Up
Brazil	9911326	➤ Sign Up
Canada	2335300	➤ Sign Up
Canada	2632433	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 7,470,720

For more information try a trial or see the plans and pricing